August 24, 2026

argenx SE (ARGX) Stock Analysis: Unpacking the 12.79% Potential Upside in Biotech Innovation

argenx SE (NASDAQ: ARGX), a trailblazer in the biotechnology sector, is capturing investor attention with its promising therapeutic pipeline and robust market performance. Based in the..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 9.41% Potential Upside Amid Healthcare Growth

Universal Health Services, Inc. (NYSE: UHS) stands as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 29.47% Potential Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands prominently in the healthcare sector as a leader among specialty and generic drug manufacturers. With a market capitalization of $22.01..

West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence

West Pharmaceutical Services, Inc. (NYSE: WST) continues to capture investor attention with its solid positioning in the healthcare sector, specifically within the medical instruments and supplies..

Summit Therapeutics Inc. (SMMT): Growth Potential and Analyst Consensus with 117.45% Upside

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a noteworthy player in the biotechnology sector, specializing in the discovery and development of innovative therapies aimed at addressing..

Penumbra, Inc. (PEN) Stock Analysis: Exploring Growth Potential and Market Position

Penumbra, Inc. (PEN), a prominent player in the healthcare sector, continues to capture investor attention with its innovative medical devices. Based in Alameda, California, Penumbra designs,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 10.46% Upside Potential Awaits Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) has been capturing attention in the healthcare sector with its solid performance and promising growth outlook. The company, established in..

BridgeBio Pharma (BBIO) Stock Analysis: Strong Buy Ratings and 33% Potential Upside Captivate Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a key player in the biotechnology sector, has been making waves with its robust pipeline of therapies aimed at genetic diseases...

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 28% Potential Upside with Innovative Biotech Solutions

For investors seeking opportunities in the biotechnology sector, TG Therapeutics, Inc. (NASDAQ: TGTX) presents an intriguing case with its robust market performance and promising pipeline. With..

Molina Healthcare Inc (MOH) Stock Analysis: A Mixed Outlook with Modest Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, presents a complex investment scenario for individual investors seeking exposure in the healthcare..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 10.87% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the healthcare sector, specifically in drug manufacturing, continues to capture investor attention with its strong presence..

STERIS plc (STE) Stock Analysis: Exploring a 10.59% Potential Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find the current profile of STERIS plc (NYSE: STE) particularly intriguing. With a market capitalization of $23.2 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare Tech Leader’s Potential Amid Market Volatility

Tempus AI, Inc. (TEM) is carving a niche in the healthcare technology sector with its pioneering integration of advanced analytics and diagnostic services. Headquartered in Chicago,..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 23.63% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology industry, capturing investor attention with its impressive growth metrics and robust pipeline of therapeutics. Based..

The Cooper Companies, Inc. (COO) Stock Analysis: Strong Buy Ratings with 6.93% Potential Upside

The Cooper Companies, Inc. (NYSE: COO) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Based in San Ramon,..

Becton, Dickinson and Company (BDX) Stock Analysis: Navigating Healthcare with a Strategic Edge

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its diverse portfolio of medical instruments and supplies...

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a 74% Potential Upside in the Vaccine Innovation Leader

Vaxcyte, Inc. (NASDAQ: PCVX), headquartered in San Carlos, California, is garnering significant attention in the biotechnology sector, largely due to its innovative approach to vaccine development...

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7% Upside Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a notable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, continues to capture investor interest..

DaVita Inc. (DVA) Stock Analysis: Potential 25.66% Upside for Healthcare Investors

DaVita Inc. (DVA) stands as a prominent player in the healthcare sector, specializing in medical care facilities with a focus on kidney dialysis services. Headquartered in..

Danaher Corporation (DHR) Investor Outlook: Strong Buy Ratings and Growth in Healthcare

Danaher Corporation (NYSE: DHR), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, has captured investor attention with its robust market..

Search

Funds

August 24, 2026

Search

Funds

August 24, 2026

FTSE 100

Funds